Fortis Healthcare Ltd. (FORTIS) 52 Week Low Streak: Why FORTIS Is Weak

Fortis Healthcare Ltd. (FORTIS) has now traded within 2% of its 52-week low for its second straight session, and the stock has moved down 7.41% across that streak. At 01 October 2026 at 10:22 AM IST, the share price was at Rs 758.35, with the latest trough at Rs 745.40. The supplied data confirms the repeated-low pattern, but it does not establish a company-specific cause for the continued decline.

The previous session’s reference point was Rs 768.20, and FORTIS was last seen opening at Rs 764.90 before touching Rs 766.95 and Rs 745.40 during the period captured here. The market capitalisation stood at Rs 61,831.07 crore. For readers, a repeated 52-week low streak is more important than a single-day dip because it shows the weakness has persisted across more than one session, even though the supplied data does not explain why.

Fortis Healthcare Ltd. 52 Week Low Streak: Consecutive Low Analysis

Metric	Value
Current Price	Rs 758.35
Previous Close	Rs 768.2
Today's Move	Rs -9.85 (-1.28%)
Open	Rs 764.9
High	Rs 766.95
Low	Rs 745.4
Market Capitalisation	Rs 61,831.07 crore

Fortis Healthcare Ltd. (FORTIS) traded at Rs 758.35 versus the previous close of Rs 768.2, a fall of 1.28%. The stock opened at Rs 764.9, reached a high of Rs 766.95, touched a low of Rs 745.4.

FORTIS was trading at Rs 758.35 versus the previous close of Rs 768.20, which means a decline of Rs 9.85 or 1.28%. The stock opened at Rs 764.90 and moved between Rs 766.95 and Rs 745.40 during the observed period, so the latest price sat in the lower half of the day range and remained close to the trough. That keeps the Fortis Healthcare Ltd. 52 Week Low Streak in focus because the price action did not shift away from the yearly low zone.

The current market capitalisation was Rs 61,831.07 crore, which places the stock among the larger names in the Indian healthcare space even as the share price stays under pressure. The key point for readers is that this is not just a one-session slip. The Fortis Healthcare Ltd. 52 Week Low Streak reflects repeated trading near the one-year low, so the market is still pricing the stock cautiously. The latest move extends the Fortis Healthcare Ltd. 52 Week Low Streak rather than interrupting it.

What the Repeated 52-Week Lows Show

The Fortis Healthcare Ltd. 52 Week Low Streak now spans a second straight session, with a cumulative fall of 7.41% across the streak. That is the most important numerical signal in this update because it captures the full stretch of weakness rather than just the latest move. The stock has been trading near its 52-week trough on consecutive sessions, which means the low-price zone is holding attention over multiple trading windows.

The supplied data confirms the pattern, but it does not confirm a company-specific trigger. That distinction matters. A repeated near-52-week-low pattern can reflect several influences, but the workflow data here only verifies the price behaviour. For this reason, the Fortis Healthcare Ltd. 52 Week Low Streak should be read as a market-action event first and a fundamental explanation only where evidence is available. In practical terms, the streak tells readers that the stock has not yet moved away from the yearly low region.

The streak also matters because it keeps the conversation on support zones and not on short-term noise. When a stock repeatedly trades near its one-year low, investors usually watch whether the decline is becoming persistent or whether the price can stabilise above the trough. On the data supplied, the Fortis Healthcare Ltd. 52 Week Low Streak remains intact.

Fortis Healthcare Ltd. (FORTIS) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 61,831.07 crore
P/E Ratio	55.35x
P/B Ratio	5.71x
ROE	11.32%
ROCE	14.07%
EPS	Rs 13.88
Book Value Per Share	Rs 134.61
Dividend Yield	0.13%

Fortis Healthcare Ltd. (FORTIS) fundamental metrics show P/E 55.35x, P/B 5.71x, ROE 11.32%, ROCE 14.07%. These figures provide context only and are not a buy or sell signal.

Fortis Healthcare Ltd. has a market capitalisation of Rs 61831.07 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 55.35x, P/B at 5.71x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 11.32% and ROCE of 14.07%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 13.88, book value per share of Rs 134.61, dividend yield of 0.13%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 39.03x, median ROE of 13.01%, median ROCE of 15.84%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Hospital & Healthcare Services
Benchmark Scope	same industry
Company P/E Ratio	55.35x
Benchmark Median P/E	39.03x
Benchmark Average P/E	87.9x
Benchmark P/E Range	0x to 1,608.25x
Company P/B Ratio	5.71x
Benchmark Median P/B	3.75x
Company ROE	11.32%
Benchmark Median ROE	13.01%
Company ROCE	14.07%
Benchmark Median ROCE	15.84%
Company Market Capitalisation	Rs 61,831.07 crore
Benchmark Median Market Cap	Rs 558.66 crore

Fortis Healthcare Ltd. (FORTIS) is classified under sector: Healthcare and industry: Hospital & Healthcare Services.

Fortis Healthcare Ltd. (FORTIS) has a P/E ratio of 55.35x, which is above the benchmark median of 39.03x, a difference of +41.81%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Fortis Healthcare Ltd. (FORTIS) has a ROE of 11.32%, which is below the benchmark median of 13.01%, a difference of -12.99%. Fortis Healthcare Ltd. (FORTIS) has a ROCE of 14.07%, which is below the benchmark median of 15.84%, a difference of -11.17%.

Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Aster DM Healthcare Ltd.	ASTERDM	64,094.07	190.26	14.33	13.07	16.22
Max Healthcare Institute Ltd.	MAXHEALTH	95,768.86	62.11	8.28	14.53	14.97
MANIPAL HEALTH ENTERPRI L	MANIPALHOS	98,508.6	104.47	5.11	12.95	13.93
Global Health Ltd.	MEDANTA	38,059.23	65.97	8.92	15.12	19.38
Narayana Hrudayalaya Ltd.	NH	36,850.34	44.89	7.72	19.86	16.2

Fortis Healthcare Ltd. (FORTIS) has a P/E ratio of 55.35x compared with the displayed peer median of 65.97x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 11.32% compares with a peer median of 14.53% across the companies shown in the table. ROCE stood at 14.07% versus the displayed peer median of 16.2%, providing a capital-efficiency comparison. Fortis Healthcare Ltd. (FORTIS) has a market capitalisation of Rs 61,831.07 crore. Among the 5 peers shown, 3 have a larger market capitalisation.

Why Investors Are Watching

• The Fortis Healthcare Ltd. 52 Week Low Streak has reached a second straight session, so the repeated-low pattern is now more than a one-day event.
• The cumulative move across the streak is -7.41%, which keeps the decline visible in both daily and multi-session terms.
• The supplied data confirms the pattern, but it does not identify a company-specific cause for the continued weakness.
• FORTIS is trading near its one-year low while still carrying a P/E and P/B above the sector median, which makes the price action more interesting for Fortis Healthcare Ltd. Stock News watchers.
• Investors tracking Stocks Hitting 52 Week Lows and 52 Week Low Stocks often watch whether the stock stabilises away from the trough or remains pinned near it.

About the Company

Fortis Healthcare Ltd. operates in the Hospital & Healthcare Services industry under the broader healthcare sector. The company is listed on NSE and BSE as FORTIS. In market terms, it has a market capitalisation of Rs 61,831.07 crore, which makes it a significant name in Indian healthcare. The Fortis Healthcare Ltd. 52 Week Low Streak is therefore being tracked in a large-cap context, without relying on any separate market-cap category label.

The company’s core financial markers supplied here include revenue-related returns captured through ROE, ROCE, EPS and book value, along with a modest dividend yield. For readers checking Fortis Healthcare Ltd. Company News, the current update is primarily about the share price pattern rather than a new operational disclosure. The repeated near-low behaviour is what stands out in this Fortis Healthcare Ltd. Stock Performance note.

Frequently Asked Questions

How many sessions has Fortis Healthcare Ltd. traded near its 52-week low?

Ans. Fortis Healthcare Ltd. has traded within 2% of its 52-week low for its second straight session. That is why this update is framed as a Fortis Healthcare Ltd. 52 Week Low Streak rather than a one-day move.

What is the cumulative move across the streak?

Ans. The supplied data shows a cumulative decline of 7.41% across the streak. That is the key multi-session figure for readers following the Fortis Healthcare Ltd. 52 Week Low Streak.

Is a company-specific reason confirmed for the weakness?

Ans. No. The supplied data confirms the repeated near-low price pattern, but it does not establish a company-specific cause for the continued decline. That distinction is important when reading the Fortis Healthcare Ltd. Stock News flow.

How does the current price compare with the day’s range?

Ans. The stock was trading at Rs 758.35, after moving between Rs 766.95 and Rs 745.40 during the observed period. That keeps the share close to the lower part of the range as part of the Fortis Healthcare Ltd. 52 Week.

Is Fortis Healthcare Ltd. cheap compared with healthcare peers?

Ans. On the supplied data, not clearly. Fortis Healthcare Ltd. trades at a P/E of 55.35 and a P/B of 5.71, both above the peer median in the same industry set. So the Fortis Healthcare Ltd. Fundamental Analysis does not show.

What do ROE and ROCE show for Fortis Healthcare Ltd.?

Ans. ROE is 11.32% and ROCE is 14.07%, both below the industry medians supplied in the dataset. That means the Fortis Healthcare Ltd. Stock Analysis needs to be read with those return ratios in mind.

How does Fortis compare with selected peers?

Ans. Fortis sits below some peers on profitability and above the industry median on valuation metrics. This makes the Fortis Healthcare Ltd. 52 Week Low Streak a notable price signal, even without a clear peer-based discount.

What should investors watch next?

Ans. Investors should watch whether the stock remains near the yearly low zone or starts trading farther away from it. They should also track future company updates, sector movement and any fresh data that could change the current Fortis Healthcare Ltd..

Track Fortis Healthcare Ltd. (FORTIS) Share Price on Univest

Use Fortis Healthcare Ltd. (FORTIS) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.